ATE401313T1 - Herstellung von risperidon - Google Patents

Herstellung von risperidon

Info

Publication number
ATE401313T1
ATE401313T1 AT07001138T AT07001138T ATE401313T1 AT E401313 T1 ATE401313 T1 AT E401313T1 AT 07001138 T AT07001138 T AT 07001138T AT 07001138 T AT07001138 T AT 07001138T AT E401313 T1 ATE401313 T1 AT E401313T1
Authority
AT
Austria
Prior art keywords
risperidone
production
disclosed
methods
present
Prior art date
Application number
AT07001138T
Other languages
German (de)
English (en)
Inventor
Barnaba Krochmal
Dov Diller
Ben-Zion Dolitzky
Judith Aronhime
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26919535&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE401313(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE401313T1 publication Critical patent/ATE401313T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT07001138T 2000-08-14 2001-08-14 Herstellung von risperidon ATE401313T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22536100P 2000-08-14 2000-08-14
US24326300P 2000-10-25 2000-10-25

Publications (1)

Publication Number Publication Date
ATE401313T1 true ATE401313T1 (de) 2008-08-15

Family

ID=26919535

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07001138T ATE401313T1 (de) 2000-08-14 2001-08-14 Herstellung von risperidon

Country Status (20)

Country Link
US (2) US6750341B2 (enExample)
EP (2) EP1317434A4 (enExample)
JP (3) JP3751942B2 (enExample)
KR (2) KR100818875B1 (enExample)
AT (1) ATE401313T1 (enExample)
AU (1) AU2001284880A1 (enExample)
CA (1) CA2419314C (enExample)
CZ (1) CZ2003668A3 (enExample)
DE (1) DE60134899D1 (enExample)
ES (1) ES2310410T3 (enExample)
HR (1) HRP20030154B1 (enExample)
HU (1) HUP0302874A2 (enExample)
IL (2) IL154417A0 (enExample)
IS (1) IS6713A (enExample)
MX (1) MXPA03001337A (enExample)
NZ (1) NZ524554A (enExample)
PL (1) PL365608A1 (enExample)
PT (1) PT1783118E (enExample)
SK (1) SK2982003A3 (enExample)
WO (1) WO2002014286A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666445B2 (en) * 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
AU2003256006A1 (en) * 2002-08-30 2004-03-19 Sunil Sadanand Nadkarni Improved process for preparation of risperidone
KR20040034996A (ko) * 2002-10-18 2004-04-29 한미약품 주식회사 리스페리돈의 개선된 제조방법
CN100390146C (zh) 2002-11-13 2008-05-28 斯索恩有限公司 制备利培酮的方法和用于该方法的中间体
US20040180935A1 (en) * 2003-02-28 2004-09-16 Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories Inc. Crystalline form Z of rabeprazole sodium and process for preparation thereof
AU2003245028A1 (en) * 2003-04-16 2004-11-04 Hetero Drugs Limited A novel crystalline form of risperidone
US7714128B2 (en) 2003-10-16 2010-05-11 Symed Labs Limited Crystalline form of linezolid
US8221778B2 (en) 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8329203B2 (en) * 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
AU2005206143B2 (en) * 2004-01-12 2010-12-16 The Trustees Of The University Of Pennsylvania Long-term delivery formulations and methods of use thereof
PL1737850T3 (pl) * 2004-04-19 2008-02-29 Symed Labs Ltd Nowy sposób wytwarzania linezolidu i związków pokrewnych
HUP0401379A3 (en) * 2004-07-08 2006-04-28 Richter Gedeon Vegyeszet Process for the preparation of risperidon
US20080262445A1 (en) * 2004-09-08 2008-10-23 Dermatrends, Inc. Transdermal Delivery of Hydrophobic Bioactive Agents
HUP0402163A2 (en) * 2004-10-25 2006-05-29 Richter Gedeon Vegyeszet Process for the preparation of risperidone
CN101198869A (zh) * 2005-04-27 2008-06-11 株式会社Umn制药 胰腺炎的预防及治疗剂
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
WO2007093870A2 (en) * 2006-02-15 2007-08-23 Orchid Chemicals & Pharmaceuticals Limited A process for the preparation of risperidone
US7820816B2 (en) * 2006-08-23 2010-10-26 Teva Pharmaceutical Industries Ltd. Process for the synthesis of CMHTP and intermediates thereof
CA2687979C (en) 2007-05-25 2017-07-04 Tolmar Therapeutics, Inc. Sustained delivery formulations of risperidone compounds
CA2750028C (en) 2009-01-20 2019-05-07 Guochuan Emil Tsai Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical
CN102786521B (zh) * 2011-05-18 2016-01-13 中国医学科学院药物研究所 利培酮晶iii型物质及制备方法与在药品和保健品中应用
CN105367570B (zh) * 2015-12-08 2017-10-10 天津市亨必达化学合成物有限公司 一种利培酮晶i型物质的制备方法
CN109563024B (zh) 2016-06-13 2023-06-06 心悦生医股份有限公司 苯甲酸锂的共晶及其用途
CN109563018A (zh) 2016-06-13 2019-04-02 心悦生医股份有限公司 苯甲酸钠的共晶及其用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US5158952A (en) * 1988-11-07 1992-10-27 Janssen Pharmaceutica N.V. 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
ES2050069B1 (es) 1992-07-10 1994-12-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-il)piperidino)etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido(1,2-a) pirimidin-4-ona.
ES2074966B1 (es) 1994-02-11 1996-06-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il)piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a)pirimidin-4-ona.
EP0877613A2 (en) * 1996-01-26 1998-11-18 PHARMACIA & UPJOHN COMPANY Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
TW487572B (en) * 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
IT1294931B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
EP1280804B1 (en) 2000-05-05 2004-04-14 RPG Life Sciences Limited A process for the preparation of anti-psychotic 3- 2- 4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4h-pyrido 1,2,-a]pyrimidin-4-one
US20020115672A1 (en) * 2000-08-08 2002-08-22 Barnaba Krochmal Preparation of risperidone
US20020193386A1 (en) 2002-03-28 2002-12-19 Inigo Pfeiffer Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof

Also Published As

Publication number Publication date
WO2002014286A9 (en) 2003-03-27
ES2310410T3 (es) 2009-01-01
EP1317434A1 (en) 2003-06-11
JP3751942B2 (ja) 2006-03-08
AU2001284880A1 (en) 2002-02-25
SK2982003A3 (en) 2004-10-05
DE60134899D1 (de) 2008-08-28
NZ524554A (en) 2005-07-29
KR20030022389A (ko) 2003-03-15
KR20080028513A (ko) 2008-03-31
CA2419314C (en) 2006-07-11
JP2008056699A (ja) 2008-03-13
MXPA03001337A (es) 2005-06-30
WO2002014286A1 (en) 2002-02-21
JP2006028192A (ja) 2006-02-02
CA2419314A1 (en) 2002-02-21
IL154417A0 (en) 2003-09-17
US7256195B2 (en) 2007-08-14
EP1982980A1 (en) 2008-10-22
HRP20030154B1 (en) 2009-03-31
HRP20030154A2 (en) 2005-04-30
HUP0302874A2 (hu) 2003-12-29
CZ2003668A3 (en) 2004-04-14
IS6713A (is) 2003-02-11
JP2004506622A (ja) 2004-03-04
KR100818875B1 (ko) 2008-04-01
US20040229905A1 (en) 2004-11-18
IL154417A (en) 2008-11-03
US6750341B2 (en) 2004-06-15
PT1783118E (pt) 2008-08-19
EP1317434A4 (en) 2005-06-22
PL365608A1 (en) 2005-01-10
US20020115673A1 (en) 2002-08-22

Similar Documents

Publication Publication Date Title
ATE401313T1 (de) Herstellung von risperidon
ATE334662T1 (de) Herstellungsverfahren von arzneizubereitungen
NO20030845D0 (no) Utvalgte fusjonerte pyrrolokarbazoler
EE05287B1 (et) Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
HUP0204235A2 (hu) Helyettesített glutárimidek és felhasználásuk IL-12 termelés inhibitorként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
CY1108085T1 (el) Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπ-2-εν-1-ονης παρασκευη και χρησης αυτων
GB0003154D0 (en) Novel compounds
CY1111693T1 (el) Αντιιικοι παραγοντες
HUP0402560A2 (hu) N-(Adamantil-metil)-származékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
MEP9509A (en) Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
MXPA03001431A (es) Polimeros de un analogo de epotilona.
BR0211473A (pt) Novos compostos
NO20032758D0 (no) Krystallinske former av Atorvastatin
FI964565A0 (fi) Menetelmiä antihistamiinisten piperidiinijohdosten vedettömien ja hydratoituneiden muotojen, niiden polymorfien ja pseudomorfien, valmistamiseksi
MEP9309A (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same
DE50205571D1 (de) Verfahren zur Herstellung von direkt tablettierbaren Beta-Mannit
AP1564A (en) Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
EP1168918A4 (en) VACCINE AND GENE THERAPY COMPOSITIONS AND METHOD FOR THEIR PRODUCTION AND USE
DE50115655D1 (de) Verfahren zur herstellung von unsymmetrischen 4,6-bis(aryloxy)pyrimidin-derivaten
WO2004007441A3 (fr) Derives de 4,4' -dithiobis- (3-aminobutane-1-sulfonates) nouveaux et compositions les contenant
ES2055503T3 (es) Diimida de silicio y procedimiento para su fabricacion, y para la fabricacion de nitruro de silicio generado a partir de la misma.
CY1105275T1 (el) Ενωσεις υποκατεστημενης γ-λακτονης ως ανταγωνισται - νμda
WO2001081298A3 (en) Cyclic carboxylic acids as integrin antagonists
MEP56208A (en) Caloporoside derivatives, methods for the production thereof and their use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties